Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03354286 · ClinicalTrials.gov registry record · NA
Supporting Parents of Young Children With Type 1 Diabetes in Closed-Loop System
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT03354286: Completed NA study, sponsored by Stanford University.
NCT03354286 is a NA study that has completed, run by Stanford University. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03354286, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
This study will examine the impact of a closed-loop insulin delivery system intervention on health and psychological outcomes in families with young children with Type 1 Diabetes (T1D).
Primary Outcome
Increasingly it is recognized that the percent time spent in a target blood glucose range, which is set by the American Diabetes Association, is an important outcome. This measure will be used as a primary outcome and derived from objective data downloads.
Interventions
- BEHAVIORAL Minimal Intervention
- BEHAVIORAL Distress Reduction
- BEHAVIORAL Developmental & Technological Demands
- BEHAVIORAL Nutrition, Set Point, & C:I Ratio
- BEHAVIORAL Hypoglycemia management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2017-11-07 |
| Est. Completion | 2019-03-18 |
| Phase | NA |
What the finished NCT03354286 record still lists
NCT03354286 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 5 interventions - of which Minimal Intervention is the first listed.
NCT03354286 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03354286 about?
NCT03354286 is a clinical study titled "Supporting Parents of Young Children With Type 1 Diabetes in Closed-Loop System". This study will examine the impact of a closed-loop insulin delivery system intervention on health and psychological outcomes in families with young children with Type 1 Diabetes (T1D).
What is the current status of trial NCT03354286?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2017-11-07. Estimated completion is 2019-03-18.
What interventions are being tested in trial NCT03354286?
The interventions under investigation include: Minimal Intervention (BEHAVIORAL), Distress Reduction (BEHAVIORAL), Developmental & Technological Demands (BEHAVIORAL), Nutrition, Set Point, & C:I Ratio (BEHAVIORAL), Hypoglycemia management (BEHAVIORAL).
Who is sponsoring clinical trial NCT03354286?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03354286's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI